Search results
Results From The WOW.Com Content Network
ICD-10 is the 10th revision of the International Classification of Diseases (ICD), a medical classification list by the World Health Organization (WHO). It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases. [ 1] Work on ICD-10 began in 1983, [ 2 ...
The International Classification of Diseases, Clinical Modification (ICD-9-CM) was an adaptation created by the US National Center for Health Statistics (NCHS) and used in assigning diagnostic and procedure codes associated with inpatient, outpatient, and physician office utilization in the United States. The ICD-9-CM is based on the ICD-9 but ...
The ICD-10 Clinical Modification ( ICD-10-CM) is a set of diagnosis codes used in the United States of America. [ 1] It was developed by a component of the U.S. Department of Health and Human services, [ 2] as an adaption of the ICD-10 with authorization from the World Health Organization. In 2015, ICD-10-CM replaced ICD-9-CM as the federally ...
The body adiposity index ( BAI) is a method of estimating the amount of body fat in humans. The BAI is calculated without using body weight, unlike the body mass index (BMI). Instead, it uses the size of the hips compared to the person's height. Based on population studies, the BAI is approximately equal to the percentage of body fat for adult ...
The ICD-10 Procedure Coding System (ICD-10-PCS) is a US system of medical classification used for procedural coding.The Centers for Medicare and Medicaid Services, the agency responsible for maintaining the inpatient procedure code set in the U.S., contracted with 3M Health Information Systems in 1995 to design and then develop a procedure classification system to replace Volume 3 of ICD-9-CM.
The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries. It is currently in its third revision (ICD-O-3). ICD-10 includes a list of ...
Dyslipidemia is a metabolic disorder characterized by abnormally high or low amounts of any or all lipids (e.g. fats, triglycerides, cholesterol, phospholipids) or lipoproteins in the blood. [ 1] Dyslipidemia is a risk factor for the development of atherosclerotic cardiovascular diseases (ASCVD), [ 1] which include coronary artery disease ...
Prevalence estimates of MHO have varied from 6 to 75 percent, [7] and it has been argued that between 10 and 25 percent of obese individuals are metabolically healthy. [8] One study found that 47.9% of obese people had MHO, while another found that 11% did. [3] It seems to be more prevalent in women than men, and its prevalence decreases with age.